These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 12803917)

  • 1. Biosynthesis and degradation of mammalian glycosphingolipids.
    Sandhoff K; Kolter T
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):847-61. PubMed ID: 12803917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.
    Schulze H; Kolter T; Sandhoff K
    Biochim Biophys Acta; 2009 Apr; 1793(4):674-83. PubMed ID: 19014978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging concepts of ganglioside metabolism.
    Sandhoff R; Sandhoff K
    FEBS Lett; 2018 Dec; 592(23):3835-3864. PubMed ID: 29802621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycolipids of the cell surface--biochemistry of their decomposition].
    Sandhoff K; Kolter T
    Naturwissenschaften; 1995 Sep; 82(9):403-13. PubMed ID: 7477413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments.
    Gillard BK; Clement R; Colucci-Guyon E; Babinet C; Schwarzmann G; Taki T; Kasama T; Marcus DM
    Exp Cell Res; 1998 Aug; 242(2):561-72. PubMed ID: 9683542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
    Sandhoff K; Klein A
    FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside Metabolism in Health and Disease.
    Sandhoff R; Schulze H; Sandhoff K
    Prog Mol Biol Transl Sci; 2018; 156():1-62. PubMed ID: 29747811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A view on sphingolipids and disease.
    Kolter T
    Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
    Sandhoff R; Sandhoff K
    Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the biochemistry of sphingolipidoses.
    Kolter T; Sandhoff K
    Brain Pathol; 1998 Jan; 8(1):79-100. PubMed ID: 9458169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular biology of glycosphingolipid glycosylation.
    Maccioni HJ; Quiroga R; Ferrari ML
    J Neurochem; 2011 May; 117(4):589-602. PubMed ID: 21371037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K; Kolter T; Van Echten-Deckert G
    Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry of glycosphingolipid degradation.
    Sandhoff K; Kolter T
    Clin Chim Acta; 1997 Oct; 266(1):51-61. PubMed ID: 9435988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside Metabolism and Its Inherited Diseases.
    Breiden B; Sandhoff K
    Methods Mol Biol; 2018; 1804():97-141. PubMed ID: 29926406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic pathways and intracellular trafficking of gangliosides.
    Daniotti JL; Iglesias-Bartolomé R
    IUBMB Life; 2011 Jul; 63(7):513-20. PubMed ID: 21698755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
    Kolter T; Sandhoff K
    Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of glycolipids: the role of glycolipid-binding proteins in the function and pathobiochemistry of lysosomes.
    Sandhoff K; van Echten G; Schröder M; Schnabel D; Suzuki K
    Biochem Soc Trans; 1992 Aug; 20(3):695-9. PubMed ID: 1426613
    [No Abstract]   [Full Text] [Related]  

  • 20. The glycosphingolipidoses-from disease to basic principles of metabolism.
    Schuette CG; Doering T; Kolter T; Sandhoff K
    Biol Chem; 1999; 380(7-8):759-66. PubMed ID: 10494825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.